Can resilience protect physiotherapists from burnout? a nationwide survey investigates

NCT ID NCT07722858

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This study surveys 400 licensed physiotherapists in Turkey to identify which factors — such as workload, organisational support, psychological resilience, self-efficacy, and Type A behaviour — best predict burnout. Participants complete an anonymous online questionnaire measuring burnout, turnover intention, and workplace stressors. The goal is to understand the relative importance of individual and workplace factors in professional burnout.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If clear predictors emerge, clinics and hospitals could design targeted support programs to reduce burnout among physiotherapists.
What could go wrong
This is a cross-sectional survey, so it can show associations but not cause and effect. Results may not apply outside Turkey.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BURNOUT, PROFESSIONAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Burnout, Professional Burnout, Psychological occupation-related stress disorder Occupational Stress

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Acibadem Mehmet Ali Aydinlar University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

    Istanbul, 34752, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.